Global Finance Changes
0
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes > Investing > RAD 202 receives approval to start Phase 1 therapeutic trial
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0 Shares
Share on Facebook Share on Twitter Share on Pinterest Share on Email
admin December 20, 2024
Previous Article Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
Next Article Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt

You Might Also Enjoy

Awalé Expands BBM Trend to Over 15km with Additional Newly Defined Targets Boba and Fett

December 20, 2024
READ MORE

Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt

December 20, 2024
READ MORE

Hempalta Corp. Announces Financial Results for Year Ended September 30, 2024

December 20, 2024
READ MORE

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

December 20, 2024
READ MORE
  • Privacy Policy
  • Terms & Conditions

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.


    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 GlobalFinanceChanges.com. All Rights Reserved.

    Our website uses cookies to improve your experience. Learn more about: Cookie Policy

    Accept